Clinical trial
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane…
NCT00071058 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00071058 |
|---|---|
| Title | Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer |
| Official title | A Study of Combination Chemotherapy & Surgical Resection in the Tx of Adrenocortical Cancer: Mitotane & Continuous Infusion Doxorubicin, Vincristine & Etoposide w/the P-glycoprotein Antagonist, Tariquidar (XR9576), Before & After Surgical Resection |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adrenal Cortex Neoplasms |
| Intervention type | Drug |
| Interventions | XR9576 (Tariquidar) |
| Enrollment | 50 |
| Start date | Oct 1, 2003 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Oct 10, 2003 |
| Last update posted | Sep 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: